153 related articles for article (PubMed ID: 35298555)
1. Investigation of the incidence trend of follicular lymphoma from 2008 to 2017 in Taiwan and the United States using population-based data.
Su YC; Chiu BC; Li HJ; Yang WC; Chen TY; Yeh SP; Wang MC; Huang WT; Lee MY; Lin SF
PLoS One; 2022; 17(3):e0265543. PubMed ID: 35298555
[TBL] [Abstract][Full Text] [Related]
2. Racial differences in three major NHL subtypes: descriptive epidemiology.
Li Y; Wang Y; Wang Z; Yi D; Ma S
Cancer Epidemiol; 2015 Feb; 39(1):8-13. PubMed ID: 25560974
[TBL] [Abstract][Full Text] [Related]
3. Incidence of extranodal non-Hodgkin lymphomas among whites, blacks, and Asians/Pacific Islanders in the United States: anatomic site and histology differences.
Wu XC; Andrews P; Chen VW; Groves FD
Cancer Epidemiol; 2009 Nov; 33(5):337-46. PubMed ID: 19853554
[TBL] [Abstract][Full Text] [Related]
4. Cancer surveillance series: non-Hodgkin's lymphoma incidence by histologic subtype in the United States from 1978 through 1995.
Groves FD; Linet MS; Travis LB; Devesa SS
J Natl Cancer Inst; 2000 Aug; 92(15):1240-51. PubMed ID: 10922409
[TBL] [Abstract][Full Text] [Related]
5. Characterizing Lymphoma Incidence and Disparities for a Cancer Center Catchment Region.
Ayers AA; Lyu L; Dance K; Ward KC; Flowers CR; Koff JL; McCullough LE
Clin Lymphoma Myeloma Leuk; 2019 Nov; 19(11):699-708.e5. PubMed ID: 31494062
[TBL] [Abstract][Full Text] [Related]
6. Distinctive incidence patterns of follicular lymphoma in Taiwan: Implications of ethnic differences.
Wu SJ; Chen YC; Lo WC; Chiang CJ; Lin CT; Chuang SS; Lai MS
Cancer Med; 2019 Apr; 8(4):1899-1907. PubMed ID: 30791222
[TBL] [Abstract][Full Text] [Related]
7. Non-Hodgkin Lymphoma - Nodal and Extranodal: 20-Year Comparative Mortality, Survival & Biologic Behavior Analysis by Age, Sex, Race, Stage, Cell Morphology/Histology, Cohort Entry Time-Period and Disease Duration: A Systematic Review of 384,651 Total NHL Cases Including 261,144 Nodal and 123,507 Extranodal Cases for Diagnosis Years 1975-2016: (SEER*Stat 8.3.6).
Milano AF
J Insur Med; 2023 Jul; 50(1):1-35. PubMed ID: 37725503
[TBL] [Abstract][Full Text] [Related]
8. Relationship between ambient ultraviolet radiation and non-Hodgkin lymphoma subtypes: a U.S. population-based study of racial and ethnic groups.
Cahoon EK; Pfeiffer RM; Wheeler DC; Arhancet J; Lin SW; Alexander BH; Linet MS; Freedman DM
Int J Cancer; 2015 Mar; 136(5):E432-41. PubMed ID: 25258118
[TBL] [Abstract][Full Text] [Related]
9. Changing incidence of non-Hodgkin lymphomas in the United States.
Clarke CA; Glaser SL
Cancer; 2002 Apr; 94(7):2015-23. PubMed ID: 11932904
[TBL] [Abstract][Full Text] [Related]
10. Contributions of Subtypes of Non-Hodgkin Lymphoma to Mortality Trends.
Howlader N; Morton LM; Feuer EJ; Besson C; Engels EA
Cancer Epidemiol Biomarkers Prev; 2016 Jan; 25(1):174-9. PubMed ID: 26472423
[TBL] [Abstract][Full Text] [Related]
11. Subtype-specific epidemiology of lymphoid malignancies in Taiwan compared to Japan and the United States, 2002-2012.
Ko BS; Chen LJ; Huang HH; Wen YC; Liao CY; Chen HM; Hsiao FY
Cancer Med; 2018 Nov; 7(11):5820-5831. PubMed ID: 30460792
[TBL] [Abstract][Full Text] [Related]
12. Colorectal cancer incidence in the United States, 1999-2004 : an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program.
Rim SH; Seeff L; Ahmed F; King JB; Coughlin SS
Cancer; 2009 May; 115(9):1967-76. PubMed ID: 19235249
[TBL] [Abstract][Full Text] [Related]
13. Influence of Rurality, Race, and Ethnicity on Non-Hodgkin Lymphoma Incidence.
Blansky D; Mantzaris I; Rohan T; Hosgood HD
Clin Lymphoma Myeloma Leuk; 2020 Oct; 20(10):668-676.e5. PubMed ID: 32605898
[TBL] [Abstract][Full Text] [Related]
14. The effects of race and ethnicity on thyroid cancer incidence.
Magreni A; Bann DV; Schubart JR; Goldenberg D
JAMA Otolaryngol Head Neck Surg; 2015 Apr; 141(4):319-23. PubMed ID: 25654447
[TBL] [Abstract][Full Text] [Related]
15. Pancreatic cancer incidence trends in the United States from 2000-2017: Analysis of Surveillance, Epidemiology and End Results (SEER) database.
Ali H; Pamarthy R; Vallabhaneni M; Sarfraz S; Ali H; Rafique H
F1000Res; 2021; 10():529. PubMed ID: 34527218
[No Abstract] [Full Text] [Related]
16. Costs associated with follicular lymphoma among individuals diagnosed with non-Hodgkin lymphoma: a longitudinal analysis using SEER-Medicare data.
Albarmawi H; Nagarajan M; Sun K; Gandhi AB; Yared J; Keating KN; Appukkuttan S; Yaldo A; Gharibo M; Onukwugha E
Leuk Lymphoma; 2020 Jan; 61(1):75-83. PubMed ID: 31389296
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular mortality among patients with non-Hodgkin lymphoma: Differences according to lymphoma subtype.
Abuamsha H; Kadri AN; Hernandez AV
Hematol Oncol; 2019 Aug; 37(3):261-269. PubMed ID: 30916804
[TBL] [Abstract][Full Text] [Related]
18. Descriptive epidemiology of pituitary tumors in the United States, 2004-2009.
Gittleman H; Ostrom QT; Farah PD; Ondracek A; Chen Y; Wolinsky Y; Kruchko C; Singer J; Kshettry VR; Laws ER; Sloan AE; Selman WR; Barnholtz-Sloan JS
J Neurosurg; 2014 Sep; 121(3):527-35. PubMed ID: 24926650
[TBL] [Abstract][Full Text] [Related]
19. Rapidly increasing incidence of ocular non-hodgkin lymphoma.
Moslehi R; Devesa SS; Schairer C; Fraumeni JF
J Natl Cancer Inst; 2006 Jul; 98(13):936-9. PubMed ID: 16818858
[TBL] [Abstract][Full Text] [Related]
20. Anthropometrics, physical activity, related medical conditions, and the risk of non-hodgkin lymphoma.
Cerhan JR; Bernstein L; Severson RK; Davis S; Colt JS; Blair A; Hartge P
Cancer Causes Control; 2005 Dec; 16(10):1203-14. PubMed ID: 16215871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
